ClinicalTrials.govpublic full text
Sodium Butyrate For Improving Cognitive Function In Schizophrenia
schizophrenic disorder, cognitive impairment, hdac inhibitors, inflammation, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 866733
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.